SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust (SLV) is seeing extreme volatility, largely driven by the CME's repeated increases in silver margin requirements, which has fueled sharp sell-offs and liquidations. The community remains fiercely divided, with many bulls actively buying dips and anticipating a massive short squeeze to much higher prices due to underlying industrial demand and impending Chinese export restrictions, while bears warn of a classic pump-and-dump scheme and expect a steep correction. The ongoing debate highlights the tension between paper market dynamics and perceived tightening physical supply.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following its long-awaited FDA approval of NEREUS (tradipitant) for motion sickness, marking the first new drug in this class in decades. Community discussions are highly focused on the drug's potential as a non-drowsy alternative and, crucially, its broader application to combat GLP-1 induced nausea, sparking significant speculation about potential buyout interest from major pharma players. Investors are actively debating immediate price action and anticipating further regulatory catalysts ahead.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is actively trending due to significant demand for its AI chips, highlighted by a substantial ByteDance order for H200s for 2026 and strategic moves like the rumored acquisition of AI21 Labs and integration of Groq's LPU technology. The community is buzzing about these developments, viewing them as solidifying Nvidia's leadership in the evolving AI landscape, particularly in countering competitors and capturing future inference workloads, despite ongoing discussions about market dynamics and geopolitical factors.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending as its stock experiences significant declines to fresh lows, sparking intense debate among investors. The community is actively discussing major broker restrictions on online share purchases and perceived market manipulation, alongside upcoming options expiry for potential volatility. Bulls, pointing to strong fundamentals and early SOX compliance, remain confident in a rebound, while skeptics express frustration over management's communication and unmet project updates.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The S&P 500 is a major talking point as the year concludes, with market participants widely discussing the absence of a strong "Santa rally" and anticipating heightened volatility. Community sentiment is divided, torn between expectations of a short-term rebound to end the year versus concerns over potential broader market weakness and concentrated tech gains. These debates reflect broader uncertainties regarding profit-taking dynamics and macro influences as traders look towards the next trading period.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is experiencing significant discussion amid anxious anticipation of an FDA decision regarding its Relacorilant treatment for Cushing's Syndrome, following a PDUFA deadline without a public announcement. This uncertainty is fueling intense speculation among the community regarding potential approval or a Complete Response Letter, driving notable price volatility and increased trading volume. Many investors are closely watching for updates while also considering the long-term potential of the company's broader pipeline in oncology and ALS.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire (RDW) is currently trending following an eight-figure contract win for European spacecraft docking systems, which is driving significant trading volume and renewed analyst interest. The community is actively discussing the company's long-term growth potential as an undervalued leader in space infrastructure and defense technology, with many anticipating a short squeeze amidst broader excitement for the space sector.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is actively discussed as it approaches its Q3 earnings report and gains inclusion in the Russell indexes, intensifying debate around its valuation. The community is split, with bulls pointing to a successful lunar landing, strategic acquisitions, and upcoming launches driving potential growth in the burgeoning space sector, while bears emphasize past launch failures and current market capitalization concerns. Broader enthusiasm for space-related ventures, including speculation around government contracts and a potential SpaceX IPO, keeps FLY squarely in the spotlight.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is actively discussed as key semiconductor companies are reportedly involved in significant AI-related investments and acquisitions, influencing broader tech sector sentiment. Community perspectives are divided, with many anticipating continued gains from the AI trade while others express caution regarding a potential 'AI Bubble' amid evolving economic data and geopolitical factors affecting global chip supply.

Rocket Cos., Inc. engages in the provision of a suite of services related to homeownership and other personal financial transactions. It operates through the following segments: Direct to Consumer and Partner Network. The Direct to Consumer segment consists of performance marketing and direct engagement through the Rocket Mortgage App. The Partner Network Segment focuses on partnerships with premier consumer-focused organizations, brokers and mortgage professionals who leverage the platform and scale to provide mortgage solutions to clients. The company was founded by Daniel Gilbert in 1985 and is headquartered in Detroit, MI.

Rocket Companies Inc - Ordinary Shares Class A

Rocket Companies (RKT) is a trending topic amidst strong community sentiment, with many anticipating a significant breakout fueled by a potential refinancing wave in 2026. Heavy institutional call buying and technical patterns suggest smart money is positioning for expected Fed rate cuts, which would amplify RKT's integrated real estate and mortgage platform leveraging recent acquisitions and AI efficiency.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oruka Therapeutics (NASDAQ:ORKA) Trading Down 3.3% - Time to Sell?

Oruka Therapeutics (NASDAQ:ORKA) Shares Down 3.3% - Here's What Happened...

Oruka Therapeutics (NASDAQ:ORKA) Reaches New 12-Month High - Here's What Happened

Oruka Therapeutics (NASDAQ:ORKA) Hits New 52-Week High - Here's What Happened...

Joana Goncalves Sells 7,000 Shares of Oruka Therapeutics (NASDAQ:ORKA) Stock

Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) insider Joana Goncalves sold 7,000 shares of the company's stock in a transaction that occurred on Friday, December 19th. The shares were sold...

Financial Enhancement Group LLC Takes Position in Oruka Therapeutics, Inc. $ORKA

Financial Enhancement Group LLC acquired a new stake in shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) during the third quarter, according to the company in its most recent 13F filing...

Oruka Therapeutics (NASDAQ:ORKA) Insider Sells $214,270.00 in Stock

Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) insider Joana Goncalves sold 7,000 shares of the firm's stock in a transaction on Friday, December 19th. The stock was sold at an average...

Oruka Therapeutics (NASDAQ:ORKA) Shares Up 11.3% - Here's What Happened

Oruka Therapeutics (NASDAQ:ORKA) Trading Up 11.3% - Time to Buy...

Piper Sandler Upgrades Oruka Therapeutics (NASDAQ:ORKA) to Strong-Buy

Piper Sandler raised shares of Oruka Therapeutics to a "strong-buy" rating in a research report on Thursday...

Braidwell LP Cuts Stake in Oruka Therapeutics, Inc. $ORKA

Braidwell LP cut its position in Oruka Therapeutics, Inc. (NASDAQ:ORKA - Free Report) by 3.0% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,524,842 shares...

Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight research firms that are currently covering the company...

Oruka Therapeutics (NASDAQ:ORKA) Reaches New 12-Month High - Should You Buy?

Oruka Therapeutics (NASDAQ:ORKA) Reaches New 1-Year High - Time to Buy...

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

ORKA
Oruka Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ORKA News

ORKAOruka Therapeutics Inc.